Faculty & Staff

doctor

Dr. Alok Srivastava

MD, FRACP, FRCPA, FRCP

Book Appointment

Senior Consultant /Department of Clinical Haematology & Bone Marrow Transplant

languageLanguages

English, Hindi, Tamil, Malayalam, Marathi
  • Overview
  • Projects
  • Publications
  • Other Contributions

 Dr. Alok Srivastava

Senior Consultant, Department of Clinical Haematology

Head, Haematology Research Unit, St. John’s Research Institute

Dr. Alok Srivastava is an internationally recognized haematologist with over three decades of leadership in bleeding disorders, stem cell transplantation, and gene therapy. After his medical training at Christian Medical College, Vellore, and advanced specialization in Australia, he has gone on to shape haematology practice and research in India and across the Asia‑Pacific region.

At St. John’s, he leads both clinical services and research programs, with a strong focus on hemophilia, bone marrow failure syndromes, and cellular therapies. He has authored hundreds of peer‑reviewed publications in leading journals such as The Lancet, New England Journal of Medicine, Blood, and Haemophilia, and holds multiple patents in gene and cell therapy.

Dr. Srivastava has served in global leadership roles with the World Federation of Hemophilia, International Society on Thrombosis and Haemostasis, and Asia‑Pacific Blood and Marrow Transplantation Group. His contributions have been recognized with prestigious awards including the Inga Marie Nilsson Award (WFH, 2012) and the Esteemed Career Award (ISTH, 2024).
 

Qualification/ Education

  • MBBS – University of Madras (1983)
  • MD (General Medicine) – University of Madras (1987)
  • FRACP – Royal Australasian College of Physicians, Internal Medicine (Haematology) (1993)
  • FRCPA – Royal College of Pathologists of Australasia, Haematology (1993)
  • FRCP (Hon.) – Royal College of Physicians, UK (2004)
  • Advanced training in Haematology & Transfusion Medicine at Christian Medical College, Vellore and Westmead Centre, Sydney, Australia.

Experience

  • Senior Consultant, Department of Clinical Haematology, St. John’s Medical College Hospital
  • Head, Haematology Research Unit, St. John’s Research Institute
  • Chairman, Asia Pacific Blood and Marrow Transplantation Group
  • Chairman, Association for Haemophilia & Allied Disorders – Asia Pacific
  • President, Indian Association for Haemophilia and Allied Disorders
  • Chair, Haematology Expert Group, Rare Diseases Consortium (ICMR, Govt. of India)
  • Chair, Technical Evaluation Committee (Human Genetics, Genome Engineering & Nanotech in Health), DBT, Govt. of India

Field of Expertise

Dr. Alok SrivastavaSenior Consultant & Head, Haematology Research Unit, SJRI
Internationally recognized expert in hemophilia, stem cell transplantation, and gene therapy with 400+ publications and global leadership rol

Extramural portfolios/ Committees

  • Head, Department of Haematology, Christian Medical College, Vellore (2006–2014)
  • Vice President (Medical), World Federation of Hemophilia (2012–2014)
  • Chair, WFH Guidelines for Management of Hemophilia (2005–2020)
  • Vice‑Chair, Center for International Blood and Marrow Transplantation Research (2011–2014)
  • President, Indian Society of Haematology and Blood Transfusion (2019–2021)
  • President, Indian Society for Blood and Marrow Transplantation (2023–2024)

Awards and Recognitions

  • Henri Chaigneau Medal – French Association of Haemophiliacs (2006)
  • Inga Marie Nilsson Award – World Federation of Hemophilia (2012)
  • International Society on Thrombosis & Haemostasis – Esteemed Career Award (2024)
  • Multiple national and international orations including Manorma Sapre Oration, J.G. Parikh Oration, Malathi Sathe Oration
  • Founding Teacher of the DM Haematology course in India (1999).
  • Guided multiple PhD theses in genetics, stem cell biology, and bone marrow failure syndromes.
  • Holds 7 patents in gene therapy, stem cell biology, and recombinant factor VIII production.
  • Over 400 peer‑reviewed publications in leading journals including The Lancet, New England Journal of Medicine, Blood, Haemophilia, J Thromb Haemost, Mol Ther.
  • Editorial roles: Associate Editor (Seminars in Thrombosis and Hemostasis, Frontiers in Alloimmunity and Transplantation), Editorial Board member (Haemophilia, J Thromb Haemost).
  • Key contributor to World Health Organization (WHO) initiatives on hemophilia and von Willebrand disease.
  • Leadership roles in World Federation of Hemophilia and International Society on Thrombosis and Haemostasis (ISTH).
  • Active in Asia‑Pacific Blood and Marrow Transplantation Group, shaping regional transplant policies and registries.

No groups and associations specified.

No project details available.

"Efficacy and safety of fitusiran prophylaxis in people with haemophilia A or haemophilia B with inhibitors (ATLAS-INH): a multicentre, open-label, randomised phase 3 trial"

Groups and Associations Guy Young 1, Alok Srivastava 2, Kaan Kavakli 3, Cecil Ross 4, Jameela Sathar 5, Chur-Woo You 6, Huyen Tran 7, Jing Sun 8, Runhui Wu 9, Stacey Poloskey 10, Zhiying Qiu 11, Salim Kichou 12, Shauna Andersson 13, Baisong Mei 13, Savita Rangarajan 14
Clinical Trial 2023
Read more

No Others Contributions details available.

Book